A phase 2 study of docetaxel in combination with indoximod in metastatic breast cancer.

被引：4
|
作者：
Soliman, Hatem Hussein
Minton, Susan E.
Ismail-Khan, Roohi
Han, Hyo S.
Vahanlan, Nicholas N.
Ramsey, William Jay
Kennedy, Eugene
Link, Charles J.
Sullivan, Daniel
Antonia, Scott Joseph
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
[2] NewLink Genet, Ames, IA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.tps3124
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS3124
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A PHASE 2 STUDY OF DOCETAXEL IN COMBINATION WITH INDOXIMOD FOR METASTATIC BREAST CANCER
    Kennedy, E. P.
    Soliman, H. H.
    Ismail-Khan, R.
    Han, H.
    Rossi, G.
    Vahanian, N.
    Link, C.
    Sullivan, D.
    Antonia, S.
    ANNALS OF ONCOLOGY, 2014, 25
  • [2] A phase I study of indoximod in combination with docetaxel in metastatic solid tumors
    Jackson, Erica
    Dees, Elizabeth Claire
    Kauh, John S.
    Harvey, R. Donald
    Neuger, Anthony
    Lush, Richard
    Antonia, Scott J.
    Minton, Susan E.
    Ismail-Khan, Roohi
    Han, Hyo S.
    Vahanian, Nicholas N.
    Ramsey, William Jay
    Link, Charles J.
    Streicher, Howard
    Sullivan, Daniel
    Soliman, Hatem Hussein
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] A phase II study of capecitabine and weekly docetaxel combination chemotherapy in patients with metastatic breast cancer.
    Puglisi, F
    Scalone, S
    Minisini, AM
    Mansutti, M
    Crivellari, D
    Buonadonna, A
    Zanetti, M
    Ermacora, P
    Piga, A
    Veronesi, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 78S - 78S
  • [4] Phase II study of gemcitabine and docetaxel in combination for the treatment of metastatic breast cancer
    Goel, Shom
    Abdi, Ehtesham
    Lewis, Craig R.
    Links, Matthew
    Begbie, Steven
    Clingan, Philip
    Ganju, Vinod
    Beith, Jane
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2009, 5 (01) : 32 - 38
  • [5] Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase I study
    Bonneterre, J.
    Campone, M.
    Koralewski, P.
    Blasinska-Morawiec, M.
    Deporte-Fety, R.
    Chatelut, E.
    Leger, F.
    Longerey, B.
    Ecochard, L.
    Douville, I.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (03) : 365 - 373
  • [6] Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase I study
    J. Bonneterre
    M. Campone
    P. Koralewski
    M. Blasinska-Morawiec
    R. Deporte-Fety
    E. Chatelut
    F. Leger
    B. Longerey
    L. Ecochard
    I. Douville
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 365 - 373
  • [7] Weekly combination of docetaxel and vinorelbine in metastatic breast cancer: A phase I/II study
    Cals, L
    Nouyrigat, P
    Valenza, B
    Pedinelli, FJ
    Juin, P
    ONCOLOGY, 2004, 67 (3-4) : 257 - 261
  • [8] A phase II study of weekly or 3-weekly docetaxel in patients with metastatic breast cancer.
    Grecea, D
    Tanasescu, R
    Vasiliniuc, C
    Neamtiu, L
    Ghilezan, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 62S - 62S
  • [9] CTEP-sponsored phase II trial of bevacizumab (Avastin™) in combination with docetaxel (Taxotere®) in metastatic breast cancer.
    Ramaswamy, B
    Rhoades, CA
    Kendra, K
    Hauger, M
    Allen, J
    Jhaveri, S
    Chen, H
    Cagnoni, P
    Eckhardt, GS
    Elias, A
    Shapiro, CL
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S50 - S50
  • [10] First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II study
    Pectasides, D
    Dimopoulos, MA
    Aravantinos, G
    Kalophonos, HP
    Papacostas, P
    Briasoulis, E
    Cogas, E
    Papadimitriou, C
    Skarlos, D
    Kosmidis, P
    Fountzilas, G
    ANTICANCER RESEARCH, 2001, 21 (05) : 3575 - 3580
12345